PISCATAWAY, N.J, April 1, 2020 /PRNewswire/ -- GenScript, a world leading biotechnology company, today announced the commercial launch of its neoantigen peptide synthesis service for biotech and ...
Collaboration set to enhance peptide discovery for challenging GPCR targets and advancing research across multiple therapeutic areas. [Glasgow, UK – 19 November 2025] – BioAscent, a leading provider ...
FUJISAWA, Japan--(BUSINESS WIRE)--SynCrest Inc., a peptide and nucleotide CRDMO (Contract Research, Development and Manufacturing Organization) joint venture between Otsuka Chemical Co., Ltd. and ...
Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents, and a pioneer in automated nanoliter-scale immunoassays, today announced the launch of three service offerings ...
LELYSTAD, the Netherlands, June 28, 2022 /PRNewswire/-- Pepscan, the all-in-one peptide service provider, is excited to announce that it will supply personalized peptide pools for six patients in a ...
GenScript now offers fast-track cGMP neoantigen peptide and peptide active pharmaceutical ingredients (API) from its new life-sciences manufacturing facility in Zhenjiang, leveraging its long history ...
DUBLIN--(BUSINESS WIRE)--The "Peptide and Oligonucleotide CDMO Market Forecast to 2033" has been added to ResearchAndMarkets.com's offering. The global peptide and oligonucleotide CDMO market is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback